See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive answer as to whether a doctor's consultation is required before receiving the MMR (measles, mumps, and rubella) vaccine after taking Cosentyx (secukinumab). However, it is generally recommended to consult with a healthcare provider before getting any vaccine, especially if you are taking any medication or have a medical condition.

Cosentyx is a medication used to treat several types of inflammatory diseases, such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is a type of drug called a monoclonal antibody that works by targeting a specific protein in the body's immune system.

According to the Centers for Disease Control and Prevention (CDC), there are no specific contraindications for the MMR vaccine in people taking biologic medications like Cosentyx. However, the CDC recommends consulting with a healthcare provider before getting the vaccine if you have a weakened immune system due to a disease or medication.

It is important to note that the MMR vaccine is a live vaccine, which means it contains a weakened form of the measles, mumps, and rubella viruses. While the vaccine is generally safe and effective, it may not be recommended for people with weakened immune systems due to the risk of infection.

Therefore, it is recommended to consult with a healthcare provider before getting the MMR vaccine after taking Cosentyx to ensure it is safe and appropriate for your individual situation.

Sources:

1. Cosentyx (secukinumab) [Internet]. Drugs.com. [cited 2023 Mar 14]. Available from: <https://www.drugs.com/cosentyx.html>.
2. MMR Vaccine: What Everyone Should Know [Internet]. Centers for Disease Control and Prevention. [cited 2023 Mar 14]. Available from: <https://www.cdc.gov/vaccines/vpd/mmr/public/index.html>.
3. Vaccine Information Statements (VISs) [Internet]. Centers for Disease Control and Prevention. [cited 2023 Mar 14]. Available from: <https://www.cdc.gov/vaccines/hcp/vis/index.html>.
4. Secukinumab [Internet]. DrugPatentWatch. [cited 2023 Mar 14]. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.